Indian markets among worst performers globally; experts see more pain ahead

Indian markets: A good tactical strategy in the near-term, according to analysts at Antique Stock Broking, is to allocate investible surplus to the Pharma sector as the coronavirus infection rate is o

Surging Covid cases across the country, elevated commodity prices and higher bond yields have punctured the market sentiment off late. The S&P BSE Sensex and the Nifty 50 have been among the worst performing major frontline indices across the globe. And if analysts and technical chartists are to be believed, there is still more pain left before the Indian markets start to look up again.

From its 52-week high of 52,516.76 hit in intra-day deals on February 16, the S&P BSE Sensex has slipped over 3,000 points, or 6 per cent till now. Only the ones in